CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Login
View profile
Log out
Welcome back

Click below to sign in and see leads, RFIs or statistics

Sign in

Sign out
- Search Impressions
  
  3 287
- Page views
  
  324
- Request for information
  
  54
Subscribe

Sanofi

About Sanofi

Sanofi Active Ingredient Solutions cover both APIs sales and Contract Development and Manufacturing. We provide expertise in Quality, Regulatory and Supply and have dedicated commercial teams for our customers around the globe.

Sales Markets

North America (USA, Canada)

Categories

Biopharmaceutical Products

Sanofi

US
2018

On CPHI since

Compare

Add to favorites Added to favorites

Contact info

(908) 981-5551
Website
55 Corporate Drive, 08807, Bridgewater, NJ, United States

Sanofi Resources (8)

News Eli Lilly, Novo Nordisk, and Sanofi cut insulin prices by up to 78%

Insulin prices have dropped in a stark play by the three biggest makers of the product, after calls from the top of the US government.

21 Mar 2023
Brochure CDMO Offering
News Sanofi to accelerate mRNA vaccines through new Center of Excellence

The company will invest €400 million per year to advance mRNA technology beyond the pandemic

29 Jun 2021
News Sanofi secures FDA approval for additional flu vaccine manufacturing plant

Commercialisation activities for the US market are already underway for Fluzone High-Dose Quadrivalent

18 Jun 2021
News Sanofi to provide fill and finish manufacturing support for Moderna vaccine

French company is now providing manufacturing capacity to support three different COVID-19 vaccines

26 Apr 2021
News Sanofi strengthens vaccines manufacturing capacity in Singapore

The company will invest €400 million in a new site to enable it to produce vaccines on a massive scale for Asia

12 Apr 2021
News Sanofi and GSK to support COVAX with 200 million doses of COVID-19 vaccine

The companies anticipate first results of Phase I/II in early December 2020, to support the initiation of a pivotal Phase III study before the end of the year.

28 Oct 2020
News Sanofi galvanizes strategic product pipeline with Principia Biopharma acquisition

The transaction will enable Sanofi to expand and accelerate development of BTK inhibitors across multiple indications, including MS and other central nervous system diseases.

17 Aug 2020